• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Syndecan-1 Attenuates Lung Injury During Influenza Infection By Potentiating c-Met Signaling to Suppress Epithelial Apoptosis

tetano

Editor, Senior Moderator
Am J Respir Crit Care Med. 2016 Mar 9. [Epub ahead of print]
[h=1]Syndecan-1 Attenuates Lung Injury During Influenza Infection By Potentiating c-Met Signaling to Suppress Epithelial Apoptosis.[/h] Brauer R[SUP]1[/SUP], Ge L[SUP]2[/SUP], Schlesinger SY[SUP]3[/SUP], Birkland TP[SUP]4[/SUP], Huang Y[SUP]5[/SUP], Parimon T[SUP]6[/SUP], Lee V[SUP]7[/SUP], McKinney BL[SUP]8[/SUP], McGuire JK[SUP]9[/SUP], Parks WC[SUP]10[/SUP], Chen P[SUP]11[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] [h=4]RATIONALE:[/h] Syndecan-1 is a cell surface heparan sulfate proteoglycan primarily expressed in the lung epithelium. Because the influenza virus is tropic to the airway epithelium, we investigated the role of syndecan-1 in influenza infection.
[h=4]OBJECTIVE:[/h] To determine the mechanism by which syndecan-1 regulates the lung mucosal response to influenza infection.
[h=4]METHODS:[/h] WT and Sdc1-/- mice were infected with a H1N1 virus (PR8) as an experimental model of influenza infection. Human and murine airway epithelial cell cultures were also infected with PR8 to study the mechanism by which syndecan-1 regulates the inflammatory response.
[h=4]MEASUREMENT AND MAIN RESULTS:[/h] We found worsened outcomes and lung injury in Sdc1-/- mice compared to WT mice after influenza infection. Our data demonstrate that syndecan-1 suppresses bronchial epithelial apoptosis during influenza infection to limit widespread lung inflammation. Furthermore, we determined that syndecan-1 attenuated apoptosis by crosstalking with c-Met to potentiate its cytoprotective signals in airway epithelial cells during influenza infection.
[h=4]CONCLUSIONS:[/h] Our work shows that cell-associated syndecan-1 has an important role in regulating lung injury. Together, our findings demonstrate a novel mechanism in which cell membrane-associated syndecan-1 regulates the innate immune response to influenza infection by facilitating cytoprotective signals through c-Met signaling to limit bronchial epithelial apoptosis thereby attenuating lung injury and inflammation.


[h=4]KEYWORDS:[/h] Influenza, lung injury, syndecan-1, proteoglycan, c-Met

PMID: 26959387 [PubMed - as supplied by publisher]
 
Back
Top Bottom